These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain. Steele TD; Nichols DE; Yim GK Biochem Pharmacol; 1987 Jul; 36(14):2297-303. PubMed ID: 2886126 [TBL] [Abstract][Full Text] [Related]
23. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine. Colado MI; Murray TK; Green AR Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129 [TBL] [Abstract][Full Text] [Related]
24. Enantiomeric differences in the effects of 3,4-methylenedioxymethamphetamine on extracellular monoamines and metabolites in the striatum of freely-moving rats: an in vivo microdialysis study. Hiramatsu M; Cho AK Neuropharmacology; 1990 Mar; 29(3):269-75. PubMed ID: 1691459 [TBL] [Abstract][Full Text] [Related]
25. Direct central effects of acute methylenedioxymethamphetamine on serotonergic neurons. Schmidt CJ; Taylor VL Eur J Pharmacol; 1988 Oct; 156(1):121-31. PubMed ID: 2463176 [TBL] [Abstract][Full Text] [Related]
26. L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats. Schmidt CJ; Black CK; Taylor VL Eur J Pharmacol; 1991 Oct; 203(1):41-9. PubMed ID: 1686766 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of dopamine release by methylenedioxymethamphetamine is mediated by serotonin. Gazzara RA; Takeda H; Cho AK; Howard SG Eur J Pharmacol; 1989 Sep; 168(2):209-17. PubMed ID: 2575036 [TBL] [Abstract][Full Text] [Related]
28. 5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine. Schmidt CJ; Fadayel GM; Sullivan CK; Taylor VL Eur J Pharmacol; 1992 Nov; 223(1):65-74. PubMed ID: 1362159 [TBL] [Abstract][Full Text] [Related]
29. Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphetamine, two metabolites of 3,4-methylenedioxymethamphetamine, on central serotonergic and dopaminergic systems. Johnson M; Elayan I; Hanson GR; Foltz RL; Gibb JW; Lim HK J Pharmacol Exp Ther; 1992 May; 261(2):447-53. PubMed ID: 1349640 [TBL] [Abstract][Full Text] [Related]
30. (+/-)-3,4-Methylenedioxymethamphetamine-induced changes in the basal activity and pharmacological responsiveness of nigrostriatal dopamine neurons. Kelland MD; Freeman AS; Chiodo LA Eur J Pharmacol; 1989 Oct; 169(1):11-21. PubMed ID: 2574685 [TBL] [Abstract][Full Text] [Related]
31. Serotonin neurotoxicity in rats after combined treatment with a dopaminergic agent followed by a nonneurotoxic 3,4-methylenedioxymethamphetamine (MDMA) analogue. Johnson MP; Huang XM; Nichols DE Pharmacol Biochem Behav; 1991 Dec; 40(4):915-22. PubMed ID: 1726189 [TBL] [Abstract][Full Text] [Related]
32. Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists. Callaway CW; Johnson MP; Gold LH; Nichols DE; Geyer MA Psychopharmacology (Berl); 1991; 104(3):293-301. PubMed ID: 1924637 [TBL] [Abstract][Full Text] [Related]
33. Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3,4-methylenedioxymethamphetamine): assessment using quantitative autoradiography. Battaglia G; Sharkey J; Kuhar MJ; de Souza EB Synapse; 1991 Aug; 8(4):249-60. PubMed ID: 1681594 [TBL] [Abstract][Full Text] [Related]
34. The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat. Yamamoto BK; Spanos LJ Eur J Pharmacol; 1988 Mar; 148(2):195-203. PubMed ID: 2897922 [TBL] [Abstract][Full Text] [Related]
35. The neurochemical and stimulatory effects of putative metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in rats. Yeh SY; Hsu FL Pharmacol Biochem Behav; 1991 Jul; 39(3):787-90. PubMed ID: 1723801 [TBL] [Abstract][Full Text] [Related]
36. The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype. Colado MI; Williams JL; Green AR Br J Pharmacol; 1995 Aug; 115(7):1281-9. PubMed ID: 7582557 [TBL] [Abstract][Full Text] [Related]
37. Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices. Johnson MP; Hoffman AJ; Nichols DE Eur J Pharmacol; 1986 Dec; 132(2-3):269-76. PubMed ID: 2880735 [TBL] [Abstract][Full Text] [Related]
38. Effect of MK-801 on the decrease in tryptophan hydroxylase induced by methamphetamine and its methylenedioxy analog. Johnson M; Hanson GR; Gibb JW Eur J Pharmacol; 1989 Jun; 165(2-3):315-8. PubMed ID: 2570704 [TBL] [Abstract][Full Text] [Related]